f1
Correspondence: Dr Niall T. Mulvihill, Unite De Cardiologie Interventionnelle, Clinique Pasteur, 45 Avenue de Lombez, 31076, Toulouse, France.

References

1
Ross
R
. Atherosclerosis: an inflammatory disease.
N Engl J Med
 .
1999
;
340
:
115
–126
2
Fuster
V
, Badimon L, Badimon J. The pathogenisis of coronary artery disease and the acute coronary syndromes.
N Engl J Med
 .
1992
;
326
:
242
–250
3
Springer
TA
. Adhesion molecules of the immune system.
Nature
 .
1990
;
346
:
425
–434
4
Cybuisky
MI
, Gimbrone MA. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis.
Science
 .
1991
;
25
:
788
–791
5
Bevilacqua
MP
, Nelson RM, Mannori G, Cecconi O. Endothelial-leukocyte adhesion molecules in human disease.
Ann Rev Med
 .
1994
;
45
:
361
–378
6
Frenette
PS
, Wagner DD. Molecular medicine: adhesion molecules.
N Engl J Med
 .
1996
;
334
:
836
–843
7
Poston
RN
, Haskard DO, Coucher JR, Gall NP, Tidey RR. Expression of the adhesion molecule ICAM-1 in atherosclerotic plaques: implications for positive feedback monocyte recruitment in the pathogenesis of the plaque.
Am J Pathol
 .
1992
;
140
:
665
–673
8
Duplaa
C
, Couffinhal T, Labat L. Monocyte/macrophage recruitment and expression of endothelial adhesion proteins in human atherosclerotic lesions.
Atherosclerosis
 .
1996
;
121
:
253
–266
9
Cybulsky
MI
, Iiyama K, Li H. A major role for VCAM-1 but not for ICAM-1 in early atherosclerosis.
J Clin Invest
 .
2001
;
107
:
1255
–1262
10
Nageh
MF
, Sandberg ET, Marotti RK. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice.
Arterioscler Thromb Vasc Biol
 .
1997
;
17
:
1517
–1520
11
Wang
K
, Zhou Z, Zhou X, Tarakji K, Topol EJ, Lincoff AM. Prevention of intimal hyperplasia with recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in the porcine coronary artery balloon injury model.
J Am Coll Cardiol
 .
2001
;
38
:
577
–582
12
Wenzel
K
, Ernst M, Rohde K. DNA polymorphisms in adhesion molecule genes—a new factor for early atherosclerosis.
Hum Genet
 .
1996
;
97
:
15
–20
13
Zheng
F
, Chevalier JA, Zhang LQ, Virgil D, Ye SQ, Kwiterovich PO. An HphI polymorphism in the E-selectin gene is associated with premature coronary artery disease.
Clin Genet
 .
2001
;
59
:
58
–64
14
Kee
F
, Morrison C, Evans AE. Polymorphisms of the P-selectin gene and risk of myocardial infarction in men and women in the ECTIM extension study.
Heart
 .
2000
;
84
:
548
–552
15
Herrmann
SM
, Ricard S, Nicaud V. The P-selectin gene is highly polymorphic: reduced frequency of the Pro715 allele carriers in patients with myocardial infarction.
Hum Mol Genet
 .
1998
;
7
:
1277
–1284
16
Barbaux
SC
, Blankenberg S, Rupprecht HJ. Association between P-selectin gene polymorphisms and soluble Pselectin levels and their relation to coronary artery disease.
Arterioscler Thromb Vasc Biol
 .
2001
;
21
:
1668
–1673
17
Gearing
AJ
, Newman W. Circulating adhesion molecules in disease.
Immunol Today
 .
1993
;
14
:
506
–512
18
Ridker
PM
, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule-1 and risk of future myocardial infarction in apparently men.
Lancet
 .
1998
;
351
:
88
–92
19
Ridker
PM
, Hennekens CH, Buring JE, Rifai N. C-Reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
N Engl J Med
 .
2000
;
342
:
836
–843
20
Ridker
PM
, Buring JE, Rifai N. Soluble P-selectin and the risk of future cardiovascular events.
Circulation
 .
2001
;
103
:
491
–495
21
Hwang
SJ
, Ballantyne CM, Sharrett AR. Circulating adhesion molecules VCAM-1, ICAM-1 and E-selectin in carotid atherosclerosis and incident coronary heart disease cases.
Circulation
 .
1997
;
96
:
4219
–4225
22
De Lemoos
JA
, Hennekens CH, Ridker PM. Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk.
J Am Coll Cardiol
 .
2000
;
36
:
423
–426
23
Jager
A
, van Hinsbergh VW, Kostense PJ. Increased levels of sVCAM-1are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study.
Diabetes
 .
2000
;
49
:
485
–491
24
Malik
I
, Danesh J, Whincup P. Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis.
Lancet
 .
2001
;
358
:
971
–975
25
Blankenberg
S
, Rupprecth HJ, Bickel C. Circulating cell adhesion molecules and death in patients with coronary artery disease.
Circulation
 .
2001
;
104
:
1336
–1342
26
Shyu
KG
, Chang H, Lin CC. Circulating ICAM-1 and E-selectin in patients with acute coronary syndrome.
Chest
 .
1996
;
109
:
1627
–1630
27
Ikeda
H
, Takajo Y, Ichiki K. Increased soluble form of P-selectin in patients with unstable angina.
Circulation
 .
1995
;
92
:
1693
–1696
28
O'Malley
T
, Ludlam CA, Riemermsa RA, Fox KA. Early increase in levels of soluble intercellular adhesion molecule-1 (sICAM-1): potential risk factor for the acute coronary syndrome.
Eur Heart J
 .
2001
;
22
:
1226
–1234
29
Mulvihill
NT
, Foley JB, Ghaisas N. Early Temporal expression of Soluble Cellular Adhesion Molecules in Unstable Angina and Subendocardial Myocardial Infarction.
Am J Cardiol
 .
1999
;
81
:
1265
–1267
30
Mulvihill
NT
, Foley JB, Murphy RT. Inflammatory markers predicting outcome in unstable angina and non Q-wave myocardial infarction.
Heart
 .
2001
;
85
:
623
–627
31
Mulcahy
R
, Daly L, Graham I. Unstable angina: natural history and determinants of prognosis.
Am J Cardiol
 .
1981
;
48
:
525
–528
32
Mulvihill
NT
, Foley JB, Murphy RT. Evidence of prolonged inflammation in unstable angina and non Q-wave myocardial infarction.
J Am Coll Cardiol
 .
2000
;
36
:
1210
–1216
33
Biasucci
LM
, Luizzo G, Grillo RL. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability.
Circulation
 .
1999
;
99
:
855
–860
34
Mulvihill
NT
, Foley BJ, Crean PA, Walsh M. Relationship between intracoronary and peripheral expression of soluble cell adhesion molecules.
Int J Cardiol
 .
2001
;
77
:
223
–229
35
Ridker
PM
, Cushman M, Stampfer MJ. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men.
N Engl J Med
 .
1997
;
336
:
973
–979
36
Braunwald
E
. Shattuck lecture—Cardiovascular medicine at the turn of the millennium: triumphs, concerns and opportunities.
N Engl J Med
 .
1997
;
337
:
1360
–1369
37
MRC/BHF Heart Protection Study, http://www.hpsinfo.org
38
Ridker
PM
, Rifai N, Clearfield M. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.
N Engl J Med
 .
2001
;
344
:
1959
–1965
This content is only available as a PDF.

Comments

0 Comments